Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice

PLx Pharma Winddown

11/04/2023 21:59

April 11 (Reuters) - PLx Pharma Inc  PLXP.O :
    * PLX PHARMA INC. RECEIVES NASDAQ DELISTING NOTICE
    * PLX PHARMA-ON APRIL 4, RECEIVED NOTICE FROM NASDAQ
INDICATING
THAT CO HAD NOT REGAINED COMPLIANCE WITH RULE, IS NOT ELIGIBLE
FOR SECOND 180-DAY PERIOD
    * PLX PHARMA INC - APRIL NOTICE ALSO STATED THAT COMPANY HAD
NOT
YET FILED ITS FORM 10-K FOR PERIOD ENDED DECEMBER 31, 2022
    * PLX PHARMA INC - COMPANY DOES NOT INTEND TO APPEAL
NASDAQ'S
DETERMINATION
    * PLX PHARMA INC - EXPECTED THAT CO'S COMMON STOCK WILL BE
DELISTED FROM NASDAQ STOCK MARKET ON APRIL 13

Source text for Eikon:  ID:nGNX4RPc2Q 
Further company coverage:  PLXP.O 

 ((Reuters.Brief@thomsonreuters.com;))